Kerrington R. Molhoek

Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin

Kerrington R. Molhoek, David L. Brautigan, Craig L. Slingluff · Journal of Translational Medicine · 2005 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)

Craig L. Slingluff, Gina R. Petroni, Kerrington R. Molhoek et al. · Clinical Cancer Research · 2013 · 38 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Evaluation of molecular markers of mesenchymal phenotype in melanoma

Leann M. Mikesh, Manish Kumar, Gulsun Erdag et al. · Melanoma Research · 2010 · 37 citations

Medicine, Cell Biology, Oncology +16

Human Melanoma Cytolysis by Combined Inhibition of Mammalian Target of Rapamycin and Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2

Kerrington R. Molhoek, Heinrich Griesemann, Jianfen Shu et al. · Cancer Research · 2008 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

The Vaccine-site Microenvironment Induced by Injection of Incomplete Freund's Adjuvant, With or Without Melanoma Peptides

Rebecca C. Harris, Kimberly A. Chianese‐Bullock, Gina R. Petroni et al. · Journal of Immunotherapy · 2011 · 34 citations · Full text

Medicine, Immunology, Oncology +17